Uraemic toxins are metabolic waste products that accumulate in patients
with kidney failure, contributing to a range of complications that affect multiple
organ systems. Peritoneal dialysis serves as an alternative to haemodialysis,
offering patients a home-based therapy that can improve their quality of life.
However, an ongoing challenge in peritoneal dialysis is the effective removal of
uraemic toxins, which are broadly classified into small water-soluble molecules,
protein-bound solutes, and middle molecules. Measuring these toxins is crucial
in understanding dialysis adequacy, guiding treatment modifications, and
improving patient outcomes. Despite its potential benefits, there are several
pitfalls associated with uraemic toxin measurement in peritoneal dialysis,
which require careful consideration.
Share this article
Journal of Nephrology & Therapeutics received 784 citations as per Google Scholar report
